Vol. 2 No. 1 (2019): MEBM

Articles

• KEY ACHIEVEMENTS IN GENE THERAPY DEVELOPMENT AND ITS PROMISING PROGRESS WITH GENE EDITING TOOLS (ZFN, TALEN, CRISPR/CAS9)

  Dina Franic, Paula Dobrinic, Petra Korac

  1-9

  • pdf
• THE VARIABILITY OF MULTI-DRUG RESISTANCE ABCB1 GENE IN THE ROMA POPULATION FROM CROATIA

  Matea Zajc Petranovic, Zeljka Tomas, Tatjana Skaric-Juric, Nina Smolej Narancic, Branka Janicijevic, Anita Stojanovic Markovic, Marijana Pericic Salihovic

  10-18

  • pdf
• LENGTH HETEROPLASMY IN THE PREDOMINATE MITOCHONDRIAL DNA HAPLOGROUPS IN THE CROATIAN POPULATION

  Lucija Barbaric, Korana Lipovac, Viktorija Sukser, Sara Rozic, Marina Korolija

  19-23

  • pdf
• HEREDITARY HEMOCHROMATOSIS GENE MUTATIONS IN PATIENTS WITH MYOCARDIAL INFARCTION

  Ivana Skrlec, Mirela Florijancic, Robert Steiner, Jasenka Wagner Kostadinovic

  24-28

  • pdf
• RESISTANCE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 TO INTEGRASE STRAND TRANSFER INHIBITORS IN CROATIA: THE FIRST REPORT

  Ana Planinic, Maja Oroz, Josip Begovac, Snjezana Zidovec Lepej

  29-33

  • pdf
• LINE-1 DNA METHYLATION AND CONGENITAL HEART DEFECTS IN DOWN SYNDROME

  Jadranka Vranekovic, Ivana Babic Bozovic, Maja Zivkovic, Aleksandra Stankovic, Bojana Brajenovic Milic

  34-37

  • pdf
• INHIBITION OF PARP ACTIVITY DOES NOT AFFECT THE DIFFERENTIATION PROCESSES CAUSED BY RETINOIC ACID IN SH-SY5Y CELLS

  Luka Horvat, Martina Grubar, Josip Madunic, Mariastefania Antica, Maja Matulic

  38-43

  • pdf
• QUANTITATIVE PCR TECHNOLOGY IN CHIMERISM STATUS EVALUATION AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

  Katarina Stingl Jankovic

  44-47

  • pdf
• INTERSTITIAL 14q31.3-q32.13 DELETION: THE ROLE OF MOLECULAR KARYOTYPING IN CLARIFYING THE ETIOLOGY OF DEVELOPMENTAL DELAY

  Kristina Crkvenac Gornik, Ivana Tonkovic Durisevic, Anita Pokupec Bilic, Sanda Huljev Frkovic

  48-51

  • pdf
• We are more than scientists...

  MEBM journal

  52

  • pdf